Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor

Yu, Jia Jia; Xiong, Fen; Xu, Yingruo; Xu, Hanyan; Zhang, Xi; Gao, Hongchang; Li, Yuping

doi:10.1016/j.intimp.2023.111412

Record: found
Abstract: not found
Article: not found

Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor

Author(s): Jia Yu , Fen Xiong , Yingruo Xu , Hanyan Xu , Xi Zhang , Hongchang Gao , Yuping Li

Publication date Created: January 2024

Publication date (Print): January 2024

Journal: International Immunopharmacology

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher PubMed

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Contributors

Yuping Li: (View ORCID Profile)

Journal

Title: International Immunopharmacology

Abbreviated Title: International Immunopharmacology

Publisher: Elsevier BV

ISSN (Print): 15675769

Publication date Created: January 2024

Publication date (Print): January 2024

Volume: 127

Page: 111412

Article

DOI: 10.1016/j.intimp.2023.111412

PubMed ID: 38160567

SO-VID: 447b759a-3d7c-4882-a437-6c3b1967498d

License:

https://www.elsevier.com/tdm/userlicense/1.0/

https://doi.org/10.15223/policy-017

https://doi.org/10.15223/policy-037

https://doi.org/10.15223/policy-012

https://doi.org/10.15223/policy-029

https://doi.org/10.15223/policy-004

History

Data availability:

Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor

Read this article at

Related collections

ChemSpider related publications

Author and article information

Contributors

Journal

Article

History

Comments

Comment on this article

Similar content 1,643

Cited by 1